European Commission granted approval of darolutamide in combination with androgen deprivation therapy (ADT) for patients with metastatic hormone-sensitive prostate cancer (mHSPC)
Spikevax is now approved for all individuals aged 6 months through 64 years at increased risk for COVID-19 disease
Emcure Pharmaceuticals successfully completes USFDA PAI of Oncology facility
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
It is intended for contrast enhancement in MRI scans
SUP will obtain regulatory approvals for selling Tiotropium DPI in China
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
The closing of the Block Acquisition is now expected to be completed by Q3 2025
This study enrolled a total of 204 healthy volunteers into three groups to compare BP16 with the reference products, Prolia, obtained from both the EU and US markets
Dupixent (dupilumab) approved as the first-ever biologic medicine in Japan for patients with Chronic Obstructive Pulmonary Disease (COPD)
Subscribe To Our Newsletter & Stay Updated
